, , p.613, 2019.
, Mycobacterium abscessus in mice, Antimicrob Agents Chemother, vol.64, pp.1943-1962
In vitro evaluation of a new drug 615 combination against clinical isolates belonging to the Mycobacterium abscessus complex, Clin 616 Microbiol Infect, vol.20, pp.1124-1127, 2014. ,
, , 2017.
, Resistance to thiacetazone derivatives active against Mycobacterium abscessus involves 619 mutations in the MmpL5 transcriptional repressor MAB_4384, Antimicrob Agents Chemother, vol.620, pp.2509-2525
, , p.622
Susceptibility testing of mycobacteria, nocardiae and other 623 aerobic actinomycetes: approved standardSecond Edition. M24-A2, 2011. ,
, , p.626
, , p.627
,
SLC24A5, a putative cation exchanger, affects pigmentation in 629 zebrafish and humans, Science, vol.310, pp.1782-1786, 2005. ,
Deciphering and 631 imaging pathogenesis and cording of Mycobacterium abscessus in zebrafish embryos, J Vis Exp, vol.632, p.53130, 2015. ,
In vivo assessment of 634 drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system, 2014. ,
, Antimicrob Agents Chemother, vol.58, pp.4054-4063
Bactericidal and 637 intracellular activity of ?-lactams against Mycobacterium abscessus, J Antimicrob Chemother, vol.638, pp.1556-1563, 2016. ,
Select ?-lactam combinations exhibit 640 synergy against Mycobacterium abscessus in vitro, Antimicrob Agents Chemother, vol.63, pp.614-633, 2019. ,
Construction of Mycobacterium abscessus defined 642 glycopeptidolipid mutants: comparison of genetic tools, Appl Environ Microbiol, vol.75, pp.1331-1338, 2009. ,
, , p.644
Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent 646 mycobacterial variants, Cell Microbiol, vol.13, pp.692-704, 2011. ,
, , p.648
Non mycobacterial virulence genes in the 649 genome of the emerging pathogen Mycobacterium abscessus, PLoS ONE, vol.4, p.5660, 2009. ,
, , p.651, 2012.
, Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug 652 candidates, Antimicrob Agents Chemother, vol.56, pp.2643-2651
, , 2017.
, Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected 655 zebrafish, Antimicrob Agents Chemother, vol.61, pp.1225-1242
, vitro 657 synergism of rifabutin with clarithromycin, p.658, 2019.
, Mycobacterium abscessus complex, Antimicrob Agents Chemother, vol.63, pp.2234-2252
In vitro and intracellular activity of rifabutin 660 on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli, J Antimicrob Chemother, vol.661, pp.355-363, 1995. ,
, , p.663
?-Lactamase inhibition by 664 avibactam in Mycobacterium abscessus, J Antimicrob Chemother, vol.70, pp.1051-1058, 2015. ,
, , 2008.
, Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr, Proc Natl, vol.667
, Acad Sci USA, vol.105, pp.4886-4891
Repositioning rifamycins for Mycobacterium abscessus 669 lung disease, Expert Opin Drug Discov, pp.1-12, 2019. ,
In vitro and intracellular activity of imipenem combined 671 with rifabutin and avibactam against Mycobacterium abscessus, Antimicrob Agents Chemother, vol.672, pp.623-641, 2018. ,
, , p.674
Mycobacteria clumping increase their capacity to damage 675 macrophages, Front Microbiol, vol.7, p.1562, 2016. ,
, , p.677
Characterization 678 of mutations conferring resistance to rifampin in Mycobacterium tuberculosis clinical strains, 2018. ,
, Antimicrob Agents Chemother, vol.62, pp.1093-1111
Mechanistic and 681 structural insights into the unique TetR-dependent regulation of a drug efflux, p.682, 2018. ,
, Mycobacterium abscessus. Front Microbiol, vol.9, p.649
, , p.684
Mutations in the MAB_2299c TetR regulator confer cross-685 resistance to clofazimine and bedaquiline in Mycobacterium abscessus, Antimicrob Agents 686 Chemother, vol.63, pp.1316-1334, 2019. ,
The TetR-family 688 transcription factor MAB_2299c regulates the expression of two distinct MmpS-MmpL efflux pumps involved in cross-resistance to clofazimine and bedaquiline in Mycobacterium abscessus, 2019. ,
, Antimicrob Agents Chemother, vol.63, pp.1000-1019
, , p.692
Rox, a rifamycin resistance enzyme with an unprecedented mechanism of 693 action, Cell Chemical Biology, vol.25, pp.403-412, 2018. ,
, , p.695
Inhibition of the ?-lactamase BlaMab by avibactam improves the in vitro and 696 in vivo efficacy of imipenem against Mycobacterium abscessus, Antimicrob Agents Chemother, vol.697, pp.2440-2456, 2017. ,
MIC values do not predict the 699 intraphagocytic killing of Staphylococcus aureus by naphthalenic ansamycins, J Antibiot, vol.700, pp.1549-1560, 1983. ,
Fast chemical force microscopy demonstrates 702 that glycopeptidolipids define nanodomains of varying hydrophobicity on mycobacteria, 2020. ,
, Nanoscale Horiz, vol.5, pp.944-953
, , p.705
Deletion of a dehydratase important for 706 intracellular growth and cording renders rough Mycobacterium abscessus avirulent, Proc Natl, vol.707, 2016. ,
, Acad Sci USA, vol.113, pp.4228-4237
Lack of 709 antimicrobial bactericidal activity in Mycobacterium abscessus, Antimicrob Agents Chemother, vol.710, pp.3828-3836, 2014. ,
In vitro and intracellular activity of imipenem combined 712 with tedizolid, rifabutin, and avibactam against Mycobacterium abscessus, Antimicrob Agents 713 Chemother, vol.63, pp.1915-1933, 2019. ,
Treatment outcomes 715 of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary 716 tuberculosis, Int J Infect Dis, vol.65, pp.135-141, 2017. ,
Treatment of Mycobacterium avium complex (MAC), vol.718, pp.351-361, 2018. ,
The clinical pharmacokinetics of rifabutin, Clin Infect Dis, vol.22, issue.720, 1996. ,
, were determined at 0, 1 and 3 dpi. Data are mean values ± SD for three independent experiments
, Data were analysed using a one-way ANOVA Kruskal-Wallis test, p.1
, macrophages at 0, 1 and 3 days post-infection after infection with M. abscessus S or (D) M. abscessus 766
Data are mean values ± SD for three independent experiments. Data were analysed using a one-767 way ANOVA Kruskal-Wallis test. (E) Percentage of S-infected macrophage categories and (F) 768 percentage of R-infected macrophage categories infected with different numbers of bacilli ,
, The categories were counted at 0 or at 1 and 3 days post-infection in the 770 absence of antibiotics or in the presence of RIF or AMK at 50 µg/mL, or RFB at 12.5 µg/mL. Values are 771 means ± SD from three independent experiments performed in triplicate. (G) Four immuno-772 fluorescent fields were taken at 1 day post-infection showing macrophages infected with M. 773 abscessus expressing Tdtomato (red). The surface and the endolysosomal system of the macrophages 774 were detected using anti-CD63 antibodies (green). The nuclei were stained with DAPI (blue), 769 5-10 bacilli and >10 bacilli)
, E-G) clinical strains belonging to S or R morphotypes at MOI of 2:1 for 3 hrs 780 prior to treatment with 250 µg/mL AMK for 2 hrs to kill extracellular bacteria. Following extensive 781 PBS washes, cells were exposed to 50 µg/mL RIF, 50 µg/mL AMK, 25 or 12.5 µg/mL RFB . CFU were determined at 0, 1 and 3 days post-infection. Data are mean values ± SD for two independent 783 experiments, Figure 3. Intracellular activity of RFB on S and R clinical isolates. CFU counts of clinical isolates 778 exposed to 25 and 12.5 µg/mL RFB. Macrophages were infected with M. abscessus (A-B) M. bolletii 779 (C-D) or M. massiliense
, A) Total number of cords 786 displayed in 20 fields at 3 days post-infection after infection of macrophages with M. abscessus R 787 variant. Data are mean values ± SD for three independent experiments performed in triplicate. Data 788 were analysed using one tailed Mann Whitney's t-test. (B) Percentage of cords formed either 789 extracellularly or intracellularly. The two categories were counted at 3 days post-infection in the 790 absence of antibiotics or in the presence of 50 µg/mL RIF
, Extracellular or intracellular cords are highlighted using the indicated colour codes. Values are means 792
C) Four immuno-793 fluorescent fields were taken at 3 days post-infection showing the cords formed extracellularly or 794 within macrophages infected with M. abscessus R variant expressing Tdtomato (red). Macrophages 795 were infected for 3 days in the presence of DMSO, RIF (50 µg/mL) ,
, White arrows indicate intracellular cords, while red arrows indicate 798 extracellular cords